Headache & Migraine
From the Journals
Health care clinicians caring for persons who experience migraine should consider screening for food insecurity as a potential contributor to...
SAN ANTONIO – The intervention also led to reductions in anxiety, depression, and stress symptoms and an increase in gray matter volume.
News from the FDA/CDC
The treatment binds to calcitonin gene-related peptide and is the first therapy to reduce the frequency of episodic cluster headache attacks.
MILWAUKEE – Pain scores and opioid use may plummet with the noninvasive therapy.
PHILADELPHIA – An orally dissolving tablet formulation has significant effects on pain relief and functional ability at 60 minutes post dose.
PHILADELPHIA – Dr. Alan Rapoport asks Dr. Stewart Tepper to summarize some of
PHILADELPHIA – The treatment appears to have the same safety and tolerability in this population as among patients...
PHILADELPHIA – Patients studied had failed to get relief from other treatments.
Patients with migraine may be willing to trade off efficacy for better adverse event profiles.
The short- and long-term disease burden of cluster headache, along with depressive symptoms, contributes to the increased risk of suicidality.